Guidelines for the therapeutic use of botulinum toxin in movement disorders.
C A
CA
Pagni
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D017408:Guidelines as Topic; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy*
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins